Encompass Health Corporation (NYSE:EHC) Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 51.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,231 shares of the company's stock after buying an additional 23,518 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.07% of Encompass Health worth $7,012,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently added to or reduced their stakes in the company. US Bancorp DE boosted its stake in Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after acquiring an additional 121 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Encompass Health by 0.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company's stock valued at $59,544,000 after buying an additional 4,345 shares during the period. Arizona State Retirement System raised its holdings in Encompass Health by 0.7% in the 4th quarter. Arizona State Retirement System now owns 29,204 shares of the company's stock valued at $2,697,000 after acquiring an additional 212 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Encompass Health during the fourth quarter worth approximately $77,944,000. Finally, Jackson Creek Investment Advisors LLC raised its position in shares of Encompass Health by 4.2% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 11,987 shares of the company's stock worth $1,107,000 after buying an additional 484 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider owned 11,958 shares in the company, valued at $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president owned 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock valued at $16,034,082 in the last ninety days. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms recently commented on EHC. Royal Bank Of Canada boosted their price target on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. UBS Group lifted their price target on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Barclays lifted their target price on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Finally, Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Eight research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $127.00.

Encompass Health Stock Up 0.1%

Shares of Encompass Health stock opened at $119.04 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. The stock has a 50 day moving average price of $119.39 and a two-hundred day moving average price of $105.37. The stock has a market capitalization of $12.00 billion, a P/E ratio of 24.60, a PEG ratio of 2.42 and a beta of 0.88. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the firm posted $1.12 earnings per share. Encompass Health's revenue was up 10.6% compared to the same quarter last year. Equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.57%. Encompass Health's payout ratio is currently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.